Lower urinary tract obstruction caused by benign prostatic hyperplasia in patients with end stage renal disease
Authors:
Vladimír Borovička; Roman Zachoval; Petr Nencka; Petr Holý; Miroslav Záleský
Authors‘ workplace:
Urologické oddělení Thomayerovy nemocnice, Praha
Published in:
Ces Urol 2013; 17(2): 100-108
Category:
Review article
Overview
Some differences exist in the diagnosis and therapy of bladder outflow obstruction between the general population and patients with end stage renal disease. They include, but are not limited to, variability in the degree of residual diuresis, altered bladder sensation, end stage renal disease-induced changes in urodynamic parameters, and differences in circadian diuresis. Understanding and recognizing these differences, as well as their implications in diagnostic and therapeutic procedures, including optimal timing of diagnosis and treatment, within this group of patients, will lead to better treatment outcomes and a lower rate of complications.
Key words:
bladder outlet obstruction, benign prostatic hyperplasia, benign prostatic obstruction, end stage renal disease.
Sources
1. Rychlík I, Lopot F. Ročenka dialyzační léčby v ČR za rok 2011. http://www.nefrol.cz/resources/upload/data/336_Rocenka2011.pdf
2. Oelke M, Bachmann A, Descazeaud A, et al. Guidelines on the management of male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). In: EAU guidelines 2012 edition. Arnhem: Drukkerij Gelderland bv 2012; 6.
3. Abrams P, Cardozo L, Fal M, et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–178.
4. Berges RR, Pientka L. Management of the BPH syndrome in Germany: who is treated and how? Eur Urol 1999; 36: 21–27.
5. Hald T. Urodynamics in benign prostatic hyperplasia: A survey. Prostate Suppl 1989; 2: 69–77.
6. Chen JL, Lee MC, Kuo HC. Reduction of cystometric bladder capacity and bladder compliance with time in patients with end-stage renal disease. J Formos Med Assoc 2012; 111(4): 209–213.
7. Turunc T, Micozkadioglu H, Dirim A, et al. Evaluation of video-urodynamic studies before renal transplantation in chronic renal failure patients. Int Urol Nephrol 2010; 42(4): 903–907.
8. Menendez V, Cofán F, Talbot-Wright R, et al. Urodynamic evaluation in simultaneous insulin dependent diabetes mellitus and end stage renal disease. J Urol 1996; 155(6): 2001–2014.
9. Sangkum P, Charermsanyakorn P, Kijvikai K, Kongcharoensombat W, Kochakarn W. Ultrastructural study of the detrusor in end stage renal disease. J Med Assoc Thai 2011; 94(10): 1218–1223.
10. Gratzke C, Pahde A, Dickmann M. Predictive factors for urinary retention following kidney transplantation in male patients. Scand J Urol Nephrol 2012; 46(1): 44–47.
11. Kirschner-Hermanns R, Daneshgari F, Vahabi B, et al. Does diabetes mellitus-induced bladder remodeling affect lower urinary tract function? ICI-RS 2011. Neurourol Urodyn 2012; 31: 359–364.
12. Kasiske BL, Snyder JJ, Gilbertson DT, Wang Ch. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4: 905–913.
13. Tanago EA, McAninch JW, et al. Smith’s General Ulology, 17th edition, New York: McGraw-Hill 2008; 539.
14. Barry JM. Current status of renal transplantation: Patient evaluations and outcomes. Urol Clin North Am 2001; 28(4): 677–686.
15. Oelke M, Kirschner-Hermanns R, Thiruchelvam N, Heesakkers J. Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS 2011. Neurourol Urodyn 2012; 31: 322–326.
16. Karam G, Kälble T, Alcaraz A, et al. Guidelines on renal transplantation. In: EAU guidelines 2012 edition. Arnhem: Drukkerij Gelderland bv 2012; 30.
17. Breza J, Navrátil P. Renal transplantation in adults. BJU International 1999; 84: 216–223.
18. Tsaur I, Jones J, Melamed RJ, et al. Postoperative voiding dysfunction in older male renal transplant recipients. Transplant Proc 2009; 41(5): 1615–1618.
19. Védrine N, Nsabimbona B, Soares P. Transurethral resection or incision of the prostate in the immediate postoperative follow-up of renal transplantation. Prog Urol 2009; 19(11): 845–849.
20. Mitsui T, Shimoda N, Morita K, et al. Lower urinary tract symptoms and their impact on quality of life after successful renal transplantation. Int J Urol 2009; 16(4): 388–392.
21. Mokos I, Kastelan Z, Basić-Jukić N, Kes P, Pasini J. Transurethral incision/resection of the prostate (TUIP/TURP) in operative treatment of repeated bladder outlet obstruction early afer kidney transplantation. Acta Clin Croat 2011; 50(3): 381–384.
22. Yamasaki T, Naganuma T, Iguchi T. et al. Association between chronic kidney disease and residual urine volumes in patients with benign prostatic hyperplasia.. Nephrology (Carlton) 2011; 16(3): 335–339.
23. Hill AM, Philpott N, Kay JD, et al. Prevalence and outcome of renal impairment at prostatectomy. Br J Urol 1993; 71: 464–468.
24. Hong SK, Lee ST, Jeong SJ, et al. Chronic kidney disease among men with lower urinary tract symptoms due to bening prostatic hyperpalsia. BJU Int. 2010; 105(10): 1424–1428.
25. Ponhonzer A, Temml Ch, Obermaye RP, et al. The association between lower urinary tract symptoms and renal function in men: a cross-sectional and 5-year longitudinal analysis. J Urol 2006; 175: 1398–1402.
26. Hilbauer J, Navrátil P, Navrátilová J. Výsledky urodynamických vyšetření u dlouhodobě anurických nemocných. Rozhl. Chir. 1982; 61(11): 782–786.
27. Wolzt M, Fabrizii V, Dorner GT, et al. Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label single-dose and multiple-dose study. Pharmacol Journal 1998; 54: 367–373.
28. Peters DH, Sorkin EM. Finasteride: a review of its potential in the treatment of benign prostatic hyperplasia. Drugs 1993; 46(1): 177–208.
29. Bissada NK. Incidence of vesicle neck contracture complicating prostatic resection in hemodialysis patients. J Urol 1977; 117(2): 192–193.
30. Shenasky JH. Renal transplantation in patients with urologic abnormalities. J Urol 1976; 115: 490–493.
31. Mizerski A, Clark Ostrowska K, Ostrowski M, et al. Postoperative adaptation of urinary bladder to variable volume of urine in the initial period following kidney transplantation. Transplant Proc 2003; 35: 2174–2175.
32. Van der Weide MJA, Hilbrands LB, Bemelmans BLH, et al. Lower urinary tract symptoms after renal transplantation. J Urol 2001; 166: 1237–1241.
33. Mitsui T, Shimoda N, Morita K, et al. Lower urinary tract symptoms and their impact on quality of life after successful renal transplantation. Int J Urol 2009; 16(4): 388–392.
34. Hurst FP, Robert TN, Edward MF, et al. Incidence, predictors, and associated outcomes of prostatism after kidney transplantation. Clin J Am Soc Nephrol 2009; 4(2): 329–336.
35. Koziolek MJ, Wolfram M, Müller GA, et al. Bening prostatic hyperpalsia (BPH) requiring transurethral resection in freshly transplanted renal. Clin Nephrol 2004; 62(1): 8–13.
36. Bauer C, Melamed ML, Hostetter TH. Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol 2008; 19(5): 844–846.
Labels
Paediatric urologist Nephrology UrologyArticle was published in
Czech Urology
2013 Issue 2
Most read in this issue
- Osteonecrosis of the jaw as an adverse effect of therapy in urological cancer patients
- A case report of hydronephrosis affecting a large segment of a horseshoe kidney
- Lower urinary tract obstruction caused by benign prostatic hyperplasia in patients with end stage renal disease
- Comparison of long term outcomes after ileal and gastric bladder augmentation